ICoreConnect Operating Margin from 2010 to 2024
| ICCT Stock | USD 0.17 0.01 5.56% |
Check ICoreConnect Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICoreConnect Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 699.2 K, Interest Expense of 2.5 M or Selling General Administrative of 13.8 M, as well as many indicators such as Price To Sales Ratio of 1.06, Dividend Yield of 0.0 or PTB Ratio of 1.95. ICoreConnect financial statements analysis is a perfect complement when working with ICoreConnect Common Valuation or Volatility modules.
ICoreConnect | Operating Margin |
Latest ICoreConnect Common's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of iCoreConnect Common stock over the last few years. It is ICoreConnect Common's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICoreConnect Common's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.88) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
ICoreConnect Operating Margin Regression Statistics
| Arithmetic Mean | (8.76) | |
| Coefficient Of Variation | (243.41) | |
| Mean Deviation | 10.26 | |
| Median | (3.41) | |
| Standard Deviation | 21.33 | |
| Sample Variance | 454.92 | |
| Range | 84.8121 | |
| R-Value | 0.39 | |
| Mean Square Error | 415.06 | |
| R-Squared | 0.15 | |
| Significance | 0.15 | |
| Slope | 1.86 | |
| Total Sum of Squares | 6,369 |
ICoreConnect Operating Margin History
About ICoreConnect Common Financial Statements
ICoreConnect Common shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although ICoreConnect Common investors may analyze each financial statement separately, they are all interrelated. The changes in ICoreConnect Common's assets and liabilities, for example, are also reflected in the revenues and expenses on on ICoreConnect Common's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthcare sector in the United States. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida. Vemics operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 55 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ICoreConnect Stock Analysis
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.